Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 229 to 236 of 236 entries
Sorted by: Best Match Show Resources per page
Association of Apparent Treatment-Resistant Hypertension With Differential Risk of End-Stage Kidney Disease Across Racial Groups in the Million Veteran Program.

Hypertension (Dallas, Tex. : 1979)

Akwo EA, Robinson-Cohen C, Chung CP, Shah SC, Brown NJ, Ikizler TA, Wilson OD, Rowan BX, Shuey MM, Siew ED, Luther JM, Giri A, Hellwege JN, Velez Edwards DR, Roumie CL, Tao R, Tsao PS, Gaziano JM, Wilson PWF, O'Donnell CJ, Edwards TL, Kovesdy CP, Hung AM.
PMID: 34148359
Hypertension. 2021 Aug;78(2):376-386. doi: 10.1161/HYPERTENSIONAHA.120.16181. Epub 2021 Jun 21.

[Figure: see text].

Cite
Akwo EA, Robinson-Cohen C, Chung CP, et al. Association of Apparent Treatment-Resistant Hypertension With Differential Risk of End-Stage Kidney Disease Across Racial Groups in the Million Veteran Program. Hypertension. 2021;78(2):376-386doi: 10.1161/HYPERTENSIONAHA.120.16181.
Akwo, E. A., Robinson-Cohen, C., Chung, C. P., Shah, S. C., Brown, N. J., Ikizler, T. A., Wilson, O. D., Rowan, B. X., Shuey, M. M., Siew, E. D., Luther, J. M., Giri, A., Hellwege, J. N., Velez Edwards, D. R., Roumie, C. L., Tao, R., Tsao, P. S., Gaziano, J. M., Wilson, P. W. F., O'Donnell, C. J., Edwards, T. L., Kovesdy, C. P., Hung, A. M. (2021). Association of Apparent Treatment-Resistant Hypertension With Differential Risk of End-Stage Kidney Disease Across Racial Groups in the Million Veteran Program. Hypertension (Dallas, Tex. : 1979), 78(2), 376-386. https://doi.org/10.1161/HYPERTENSIONAHA.120.16181
Akwo, Elvis A, et al. "Association of Apparent Treatment-Resistant Hypertension With Differential Risk of End-Stage Kidney Disease Across Racial Groups in the Million Veteran Program." Hypertension (Dallas, Tex. : 1979) vol. 78,2 (2021): 376-386. doi: https://doi.org/10.1161/HYPERTENSIONAHA.120.16181
Akwo EA, Robinson-Cohen C, Chung CP, Shah SC, Brown NJ, Ikizler TA, Wilson OD, Rowan BX, Shuey MM, Siew ED, Luther JM, Giri A, Hellwege JN, Velez Edwards DR, Roumie CL, Tao R, Tsao PS, Gaziano JM, Wilson PWF, O'Donnell CJ, Edwards TL, Kovesdy CP, Hung AM. Association of Apparent Treatment-Resistant Hypertension With Differential Risk of End-Stage Kidney Disease Across Racial Groups in the Million Veteran Program. Hypertension. 2021 Aug;78(2):376-386. doi: 10.1161/HYPERTENSIONAHA.120.16181. Epub 2021 Jun 21. PMID: 34148359; PMCID: PMC8364328.
Copy Download .nbib Format: NLM
Functional and Radiological Improvement in a COVID-19 Pneumonia Patient Treated With Steroids.

Cureus

Singh R, Gaziano D.
PMID: 34188995
Cureus. 2021 May 26;13(5):e15257. doi: 10.7759/cureus.15257.

Like its predecessors, coronavirus disease 2019 (COVID-19) can lead to long-term health-related consequences in a significant segment of the afflicted population. Although the medical community has developed multiple vaccines by now, COVID-19 has affected over 100 million individuals worldwide...

Cite
Singh R, Gaziano D. Functional and Radiological Improvement in a COVID-19 Pneumonia Patient Treated With Steroids. Cureus. 2021;13(5):e15257doi: 10.7759/cureus.15257.
Singh, R., & Gaziano, D. (2021). Functional and Radiological Improvement in a COVID-19 Pneumonia Patient Treated With Steroids. Cureus, 13(5), e15257. https://doi.org/10.7759/cureus.15257
Singh, Rahul, and Gaziano, Dominic. "Functional and Radiological Improvement in a COVID-19 Pneumonia Patient Treated With Steroids." Cureus vol. 13,5 (2021): e15257. doi: https://doi.org/10.7759/cureus.15257
Singh R, Gaziano D. Functional and Radiological Improvement in a COVID-19 Pneumonia Patient Treated With Steroids. Cureus. 2021 May 26;13(5):e15257. doi: 10.7759/cureus.15257. PMID: 34188995; PMCID: PMC8231732.
Copy Download .nbib Format: NLM
Trajectories of Frailty in the 5 Years Prior to Death Among U.S. Veterans Born 1927-1934.

The journals of gerontology. Series A, Biological sciences and medical sciences

Ward RE, Orkaby AR, Dumontier C, Charest B, Hawley CE, Yaksic E, Quach L, Kim DH, Gagnon DR, Gaziano JM, Cho K, Djousse L, Driver JA.
PMID: 34244759
J Gerontol A Biol Sci Med Sci. 2021 Oct 13;76(11):e347-e353. doi: 10.1093/gerona/glab196.

BACKGROUND: Electronic frailty indices (eFIs) are increasingly used to identify patients at risk for morbidity and mortality. Whether eFIs capture the spectrum of frailty change, including decline, stability, and improvement, is unknown.METHODS: In a nationwide retrospective birth cohort of...

Cite
Ward RE, Orkaby AR, Dumontier C, et al. Trajectories of Frailty in the 5 Years Prior to Death Among U.S. Veterans Born 1927-1934. J Gerontol A Biol Sci Med Sci. 2021;76(11):e347-e353doi: 10.1093/gerona/glab196.
Ward, R. E., Orkaby, A. R., Dumontier, C., Charest, B., Hawley, C. E., Yaksic, E., Quach, L., Kim, D. H., Gagnon, D. R., Gaziano, J. M., Cho, K., Djousse, L., & Driver, J. A. (2021). Trajectories of Frailty in the 5 Years Prior to Death Among U.S. Veterans Born 1927-1934. The journals of gerontology. Series A, Biological sciences and medical sciences, 76(11), e347-e353. https://doi.org/10.1093/gerona/glab196
Ward, Rachel E, et al. "Trajectories of Frailty in the 5 Years Prior to Death Among U.S. Veterans Born 1927-1934." The journals of gerontology. Series A, Biological sciences and medical sciences vol. 76,11 (2021): e347-e353. doi: https://doi.org/10.1093/gerona/glab196
Ward RE, Orkaby AR, Dumontier C, Charest B, Hawley CE, Yaksic E, Quach L, Kim DH, Gagnon DR, Gaziano JM, Cho K, Djousse L, Driver JA. Trajectories of Frailty in the 5 Years Prior to Death Among U.S. Veterans Born 1927-1934. J Gerontol A Biol Sci Med Sci. 2021 Oct 13;76(11):e347-e353. doi: 10.1093/gerona/glab196. PMID: 34244759.
Copy Download .nbib Format: NLM
Risk factors and prediction models for incident heart failure with reduced and preserved ejection fraction.

ESC heart failure

Gaziano L, Cho K, Djousse L, Schubert P, Galloway A, Ho YL, Kurgansky K, Gagnon DR, Russo JP, Di Angelantonio E, Wood AM, Danesh J, Gaziano JM, Butterworth AS, Wilson PWF, Joseph J.
PMID: 34528757
ESC Heart Fail. 2021 Dec;8(6):4893-4903. doi: 10.1002/ehf2.13429. Epub 2021 Sep 16.

AIMS: This study aims to develop the first race-specific and sex-specific risk prediction models for heart failure with preserved (HFpEF) and reduced ejection fraction (HFrEF).METHODS AND RESULTS: We created a cohort of 1.8 million individuals who had an outpatient...

Cite
Gaziano L, Cho K, Djousse L, et al. Risk factors and prediction models for incident heart failure with reduced and preserved ejection fraction. ESC Heart Fail. 2021;8(6):4893-4903doi: 10.1002/ehf2.13429.
Gaziano, L., Cho, K., Djousse, L., Schubert, P., Galloway, A., Ho, Y. L., Kurgansky, K., Gagnon, D. R., Russo, J. P., Di Angelantonio, E., Wood, A. M., Danesh, J., Gaziano, J. M., Butterworth, A. S., Wilson, P. W. F., & Joseph, J. (2021). Risk factors and prediction models for incident heart failure with reduced and preserved ejection fraction. ESC heart failure, 8(6), 4893-4903. https://doi.org/10.1002/ehf2.13429
Gaziano, Liam, et al. "Risk factors and prediction models for incident heart failure with reduced and preserved ejection fraction." ESC heart failure vol. 8,6 (2021): 4893-4903. doi: https://doi.org/10.1002/ehf2.13429
Gaziano L, Cho K, Djousse L, Schubert P, Galloway A, Ho YL, Kurgansky K, Gagnon DR, Russo JP, Di Angelantonio E, Wood AM, Danesh J, Gaziano JM, Butterworth AS, Wilson PWF, Joseph J. Risk factors and prediction models for incident heart failure with reduced and preserved ejection fraction. ESC Heart Fail. 2021 Dec;8(6):4893-4903. doi: 10.1002/ehf2.13429. Epub 2021 Sep 16. PMID: 34528757; PMCID: PMC8712836.
Copy Download .nbib Format: NLM
Evaluation of the Usage and Dosing of Guideline-Directed Medical Therapy for Heart Failure With Reduced Ejection Fraction Patients in Clinical Practice.

Journal of pharmacy practice

Smith KV, Dunning JR, Fischer CM, MacLean TE, Bosque-Hamilton JW, Fera LE, Grant JY, Zelle DJ, Matta L, Gaziano TA, MacRae CA, Scirica BM, Desai AS.
PMID: 33813934
J Pharm Pract. 2021 Apr 05;8971900211004840. doi: 10.1177/08971900211004840. Epub 2021 Apr 05.

BACKGROUND: Although strategies for optimization of pharmacologic therapy in patients with heart failure with reduced ejection fraction (HFrEF) are scripted by guidelines, data from HF registries suggests that guideline-directed medical therapies (GDMT) are underutilized among eligible patients. Whether this...

Cite
Smith KV, Dunning JR, Fischer CM, et al. Evaluation of the Usage and Dosing of Guideline-Directed Medical Therapy for Heart Failure With Reduced Ejection Fraction Patients in Clinical Practice. J Pharm Pract. 2021;8971900211004840doi: 10.1177/08971900211004840.
Smith, K. V., Dunning, J. R., Fischer, C. M., MacLean, T. E., Bosque-Hamilton, J. W., Fera, L. E., Grant, J. Y., Zelle, D. J., Matta, L., Gaziano, T. A., MacRae, C. A., Scirica, B. M., & Desai, A. S. (2021). Evaluation of the Usage and Dosing of Guideline-Directed Medical Therapy for Heart Failure With Reduced Ejection Fraction Patients in Clinical Practice. Journal of pharmacy practice, 8971900211004840. https://doi.org/10.1177/08971900211004840
Smith, Katelyn V, et al. "Evaluation of the Usage and Dosing of Guideline-Directed Medical Therapy for Heart Failure With Reduced Ejection Fraction Patients in Clinical Practice." Journal of pharmacy practice vol. (2021): 8971900211004840. doi: https://doi.org/10.1177/08971900211004840
Smith KV, Dunning JR, Fischer CM, MacLean TE, Bosque-Hamilton JW, Fera LE, Grant JY, Zelle DJ, Matta L, Gaziano TA, MacRae CA, Scirica BM, Desai AS. Evaluation of the Usage and Dosing of Guideline-Directed Medical Therapy for Heart Failure With Reduced Ejection Fraction Patients in Clinical Practice. J Pharm Pract. 2021 Apr 05;8971900211004840. doi: 10.1177/08971900211004840. Epub 2021 Apr 05. PMID: 33813934.
Copy Download .nbib Format: NLM
Comparative Effectiveness of BNT162b2 and mRNA-1273 Vaccines in U.S. Veterans.

The New England journal of medicine

Dickerman BA, Gerlovin H, Madenci AL, Kurgansky KE, Ferolito BR, Figueroa Muñiz MJ, Gagnon DR, Gaziano JM, Cho K, Casas JP, Hernán MA.
PMID: 34942066
N Engl J Med. 2022 Jan 13;386(2):105-115. doi: 10.1056/NEJMoa2115463. Epub 2021 Dec 01.

BACKGROUND: The messenger RNA (mRNA)-based vaccines BNT162b2 and mRNA-1273 are more than 90% effective against coronavirus disease 2019 (Covid-19). However, their comparative effectiveness for a range of outcomes across diverse populations is unknown.METHODS: We emulated a target trial using...

Cite
Dickerman BA, Gerlovin H, Madenci AL, et al. Comparative Effectiveness of BNT162b2 and mRNA-1273 Vaccines in U.S. Veterans. N Engl J Med. 2021;386(2):105-115doi: 10.1056/NEJMoa2115463.
Dickerman, B. A., Gerlovin, H., Madenci, A. L., Kurgansky, K. E., Ferolito, B. R., Figueroa Muñiz, M. J., Gagnon, D. R., Gaziano, J. M., Cho, K., Casas, J. P., & Hernán, M. A. (2022). Comparative Effectiveness of BNT162b2 and mRNA-1273 Vaccines in U.S. Veterans. The New England journal of medicine, 386(2), 105-115. https://doi.org/10.1056/NEJMoa2115463
Dickerman, Barbra A, et al. "Comparative Effectiveness of BNT162b2 and mRNA-1273 Vaccines in U.S. Veterans." The New England journal of medicine vol. 386,2 (2022): 105-115. doi: https://doi.org/10.1056/NEJMoa2115463
Dickerman BA, Gerlovin H, Madenci AL, Kurgansky KE, Ferolito BR, Figueroa Muñiz MJ, Gagnon DR, Gaziano JM, Cho K, Casas JP, Hernán MA. Comparative Effectiveness of BNT162b2 and mRNA-1273 Vaccines in U.S. Veterans. N Engl J Med. 2022 Jan 13;386(2):105-115. doi: 10.1056/NEJMoa2115463. Epub 2021 Dec 01. PMID: 34942066; PMCID: PMC8693691.
Copy Download .nbib Format: NLM
Population health management of low-density lipoprotein cholesterol via a remote, algorithmic, navigator-executed program.

American heart journal

Plutzky J, Benson MD, Chaney K, Bui TV, Kraft M, Matta L, McPartlin M, Zelle D, Cannon CP, Dodek A, Gaziano TA, Desai AS, MacRae CA, Scirica BM.
PMID: 34481756
Am Heart J. 2022 Jan;243:15-27. doi: 10.1016/j.ahj.2021.08.017. Epub 2021 Sep 03.

BACKGROUND: Implementation of guideline-directed cholesterol management remains low despite definitive evidence establishing such measures reduce cardiovascular (CV) events, especially in high atherosclerotic CV disease (ASCVD) risk patients. Modern electronic resources now exist that may help improve health care delivery....

Cite
Plutzky J, Benson MD, Chaney K, et al. Population health management of low-density lipoprotein cholesterol via a remote, algorithmic, navigator-executed program. Am Heart J. 2021;243:15-27doi: 10.1016/j.ahj.2021.08.017.
Plutzky, J., Benson, M. D., Chaney, K., Bui, T. V., Kraft, M., Matta, L., McPartlin, M., Zelle, D., Cannon, C. P., Dodek, A., Gaziano, T. A., Desai, A. S., MacRae, C. A., & Scirica, B. M. (2022). Population health management of low-density lipoprotein cholesterol via a remote, algorithmic, navigator-executed program. American heart journal, 24315-27. https://doi.org/10.1016/j.ahj.2021.08.017
Plutzky, Jorge, et al. "Population health management of low-density lipoprotein cholesterol via a remote, algorithmic, navigator-executed program." American heart journal vol. 243 (2022): 15-27. doi: https://doi.org/10.1016/j.ahj.2021.08.017
Plutzky J, Benson MD, Chaney K, Bui TV, Kraft M, Matta L, McPartlin M, Zelle D, Cannon CP, Dodek A, Gaziano TA, Desai AS, MacRae CA, Scirica BM. Population health management of low-density lipoprotein cholesterol via a remote, algorithmic, navigator-executed program. Am Heart J. 2022 Jan;243:15-27. doi: 10.1016/j.ahj.2021.08.017. Epub 2021 Sep 03. PMID: 34481756.
Copy Download .nbib Format: NLM
Rapid establishment of a frontline field laboratory in response to an imported outbreak of Ebola virus disease in western Uganda, June 2019.

PLoS neglected tropical diseases

Schuh AJ, Kyondo J, Graziano J, Balinandi S, Kainulainen MH, Tumusiime A, Nyakarahuka L, Mulei S, Baluku J, Lonergan W, Mayer O, Masereka R, Masereka F, Businge E, Gatare A, Kabyanga L, Muhindo S, Mugabe R, Makumbi I, Kayiwa J, Wetaka MM, Brown V, Ojwang J, Nelson L, Millard M, Nichol ST, Montgomery JM, Taboy CH, Lutwama JJ, Klena JD.
PMID: 34860831
PLoS Negl Trop Dis. 2021 Dec 03;15(12):e0009967. doi: 10.1371/journal.pntd.0009967. eCollection 2021 Dec.

The Democratic Republic of the Congo (DRC) declared an Ebola virus disease (EVD) outbreak in North Kivu in August 2018. By June 2019, the outbreak had spread to 26 health zones in northeastern DRC, causing >2,000 reported cases and...

Cite
Schuh AJ, Kyondo J, Graziano J, et al. Rapid establishment of a frontline field laboratory in response to an imported outbreak of Ebola virus disease in western Uganda, June 2019. PLoS Negl Trop Dis. 2021;15(12):e0009967doi: 10.1371/journal.pntd.0009967.
Schuh, A. J., Kyondo, J., Graziano, J., Balinandi, S., Kainulainen, M. H., Tumusiime, A., Nyakarahuka, L., Mulei, S., Baluku, J., Lonergan, W., Mayer, O., Masereka, R., Masereka, F., Businge, E., Gatare, A., Kabyanga, L., Muhindo, S., Mugabe, R., Makumbi, I., Kayiwa, J., Wetaka, M. M., Brown, V., Ojwang, J., Nelson, L., Millard, M., Nichol, S. T., Montgomery, J. M., Taboy, C. H., Lutwama, J. J., & Klena, J. D. (2021). Rapid establishment of a frontline field laboratory in response to an imported outbreak of Ebola virus disease in western Uganda, June 2019. PLoS neglected tropical diseases, 15(12), e0009967. https://doi.org/10.1371/journal.pntd.0009967
Schuh, Amy J, et al. "Rapid establishment of a frontline field laboratory in response to an imported outbreak of Ebola virus disease in western Uganda, June 2019." PLoS neglected tropical diseases vol. 15,12 (2021): e0009967. doi: https://doi.org/10.1371/journal.pntd.0009967
Schuh AJ, Kyondo J, Graziano J, Balinandi S, Kainulainen MH, Tumusiime A, Nyakarahuka L, Mulei S, Baluku J, Lonergan W, Mayer O, Masereka R, Masereka F, Businge E, Gatare A, Kabyanga L, Muhindo S, Mugabe R, Makumbi I, Kayiwa J, Wetaka MM, Brown V, Ojwang J, Nelson L, Millard M, Nichol ST, Montgomery JM, Taboy CH, Lutwama JJ, Klena JD. Rapid establishment of a frontline field laboratory in response to an imported outbreak of Ebola virus disease in western Uganda, June 2019. PLoS Negl Trop Dis. 2021 Dec 03;15(12):e0009967. doi: 10.1371/journal.pntd.0009967. eCollection 2021 Dec. PMID: 34860831; PMCID: PMC8673597.
Copy Download .nbib Format: NLM
Showing 229 to 236 of 236 entries